Reply to capecitabine dosing is not yet optimized for breast cancer

  1. Zielinski, C.
  2. Gralow, J.
  3. Martin, M.
Revue:
Annals of Oncology

ISSN: 1569-8041,  0923-7534

Année de publication: 2010

Volumen: 21

Número: 11

Pages: 2291-2292

Type: Lettre

DOI: 10.1093/ANNONC/MDQ265 GOOGLE SCHOLAR lock_openAccès ouvert editor
La source de données: Scopus